Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/11/17 → 6/30/18 |
Financiación
- Bristol Myers Squibb Company: 10.000,00 US$
Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-936558 (nivolumab) in Participants with Severe Sepsis or Septic Shock
- Morris, Peter (PI)
- Montgomery-Yates, Ashley (CoI)